Retour sur lavenir.net
   ARGENX SE 759.200 € (-2,11 %)     GBL 79.200 € (+1,15 %)     VAN DE VELDE 29.800 € (-0,67 %)     BEKAERT 39.850 € (-5,01 %)     AB INBEV 72.620 € (-1,73 %)     SYENSQO 77.500 € (+8,47 %)     AGEAS 71.400 € (+0,71 %)     MONTEA 68.200 € (-0,15 %)     BELYSSE GROUP 0.495 € (-2,94 %)     BIOTALYS 2.400 € (+0,84 %)     KBC 121.450 € (+0,45 %)     COLRUYT 39.340 € (+1,34 %)     SOLVAY 26.920 € (+0,67 %)     MELEXIS 68.050 € (+1,57 %)     KINEPOLIS GROUP 41.000 € (-1,09 %)     FAGRON 23.350 € (-0,21 %)     ORANGE BELGIUM 22.100 € (-0,45 %)     ELIA GROUP 126.700 € (-1,09 %)     AEDIFICA 71.250 € (-0,21 %)     CELYAD ONCOLOGY 0.270 € (-1,10 %)     UCB 229.500 € (-8,53 %)     TUBIZE-FIN 197.200 € (-7,85 %)     DEME GROUP 166.800 € (+1,58 %)     VGP 86.100 € (+0,12 %)     ONTEX GROUP 2.235 € (-6,68 %)     UMICORE 20.680 € (+2,68 %)     AZELIS GROUP 11.840 € (+3,95 %)     CMB.TECH 13.740 € (+0,73 %)     KBC ANCORA 86.600 € (+0,58 %)     ACKERMANS V.HAAREN 268.600 € (+1,97 %)     ONWARD MEDICAL 2.370 € (0,00 %)     D'IETEREN GROUP 183.300 € (+0,94 %)     SHURGARD 25.900 € (+1,17 %)     VIOHALCO 17.020 € (-0,23 %)     RECTICEL 12.120 € (-0,16 %)     BREDERODE 102.800 € (+0,39 %)     SOFINA 244.000 € (+0,74 %)     NYRSTAR 0.060 € (0,00 %)     WDP 22.600 € (0,00 %)     NYXOAH 1.252 € (+0,48 %)     PROXIMUS 6.370 € (+0,08 %)     BPOST 1.532 € (+0,26 %)     GIMV 44.500 € (+0,23 %)     IBA 16.080 € (+0,88 %)     HOME INVEST BE. 20.450 € (+2,00 %)     EVS 27.400 € (-0,72 %)     CFE 11.900 € (-0,83 %)     XIOR 28.200 € (+0,89 %)     BARCO 8.005 € (+1,20 %)     AGFA-GEVAERT 0.386 € (+0,13 %)     TITAN S.A. 52.050 € (+0,77 %)     LOTUS BAKERIES 11 400.000 € (+0,88 %)     SOLVAC NOM(RETAIL) 79.500 € (+5,30 %)     VASTNED 29.400 € (+0,86 %)     CARE PROPERTY INV. 12.800 € (+0,31 %)     DECEUNINCK 2.240 € (+1,36 %)     TESSENDERLO 21.350 € (+2,64 %)     IMMOBEL 21.300 € (+0,47 %)     OPTION 4.390 € (-2,66 %)     BANQUP GROUP 2.100 € (+3,45 %)  
   LOUIS HACHETTE 1.796 € (+1,24 %)     AYVENS 12.130 € (+4,84 %)     METAVISIO 0.001 € (-9,09 %)     CVC CAPITAL 14.860 € (+3,12 %)     FDJ UNITED 22.270 € (-3,17 %)     MOTA ENGIL 4.658 € (+3,10 %)     GALP ENERGIA-NOM 19.960 € (-0,18 %)     CLARIANE 4.060 € (+0,25 %)     BOLLORE 4.004 € (-1,81 %)     MEDIANTECHNOLOGIES 4.020 € (+1,77 %)     MEDINCELL 26.280 € (+0,31 %)     STMICROELECTRONICS 43.450 € (+1,29 %)     B.COM.PORTUGUES 1.042 € (+2,46 %)     FASTNED 33.800 € (+2,27 %)     ASM INTERNATIONAL 743.600 € (+3,28 %)     SES 5.655 € (-16,35 %)     VINCI 124.100 € (+4,90 %)     EDP 4.464 € (-0,87 %)     EUROFINS SCIENT. 69.120 € (+0,70 %)     VEOLIA ENVIRON. 35.650 € (+1,42 %)     SHELL PLC 39.360 € (+1,36 %)     GTT 195.300 € (+1,30 %)     ID LOGISTICS GROUP 368.500 € (+1,24 %)     TOTALENERGIES 75.560 € (-0,36 %)     PUBLICIS GROUPE SA 95.620 € (+0,63 %)     SANOFI 77.090 € (-3,54 %)     SMCP 6.300 € (+1,53 %)     EUTELSAT COMMUNIC. 1.976 € (-4,49 %)     SOCIETE GENERALE 78.370 € (+2,15 %)     RENAULT 27.930 € (+0,07 %)     ESSILORLUXOTTICA 167.850 € (+1,67 %)     THALES 244.400 € (-0,41 %)     LEGRAND 126.350 € (-1,83 %)     ING GROEP N.V. 29.330 € (+2,02 %)     HAFFNER ENERGY 0.291 € (-1,53 %)     DSM FIRMENICH AG 93.940 € (+12,66 %)     L'OREAL 398.650 € (+3,95 %)     UNILEVER 57.960 € (-0,80 %)     ADYEN 885.100 € (+0,47 %)     QUADIENT 13.520 € (+0,45 %)     PROSUS 39.500 € (+0,01 %)     LVMH 474.100 € (+1,31 %)     PHARMING GROUP 0.840 € (-23,55 %)     EUROAPI 0.942 € (-25,36 %)     SCHNEIDER ELECTRIC 272.450 € (+6,09 %)     CAPGEMINI 105.600 € (-1,40 %)     SOITEC 97.120 € (+0,96 %)     REXEL 35.150 € (+0,63 %)     BE SEMICONDUCTOR 189.050 € (-0,24 %)     ACCOR 46.700 € (-1,25 %)     AIR LIQUIDE 171.560 € (+0,05 %)     VICAT 70.100 € (+13,80 %)     BNP PARIBAS ACT.A 107.120 € (+0,19 %)     ARCELORMITTAL SA 57.880 € (+0,17 %)     NN GROUP 80.540 € (+0,50 %)     HERMES INTL 1 546.000 € (+2,49 %)     EURAZEO 46.740 € (+1,17 %)     CREDIT AGRICOLE 18.580 € (+1,14 %)     TECHNIP ENERGIES 27.880 € (-14,53 %)     APERAM 44.160 € (-4,37 %)  
News Réglementées
30/07/2026 09:00

Original-Research: Nabaltec AG (von NuWays AG): BUY

Original-Research: Nabaltec AG - from NuWays AG

30.07.2026 / 09:00 CET/CEST
Dissemination of a Research, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this research. The result of this research does not constitute investment advice or an invitation to conclude certain stock exchange transactions.


Classification of NuWays AG to Nabaltec AG

Company Name:Nabaltec AG
ISIN:DE000A0KPPR7
 
Reason for the research:Update
Recommendation:BUY
Target price:EUR 16
Target price on sight of:12 months
Last rating change:
Analyst:Christian Sandherr

Q2 preview: Passed the trough, returning to growth

Nabaltec will publish its H1 figures on August 20. Following a soft Q1 (sales -2.7% yoy), management guided for a gradual return to revenue growth starting from Q2, driven by a broad-based demand pick-up. The release should hence serve as the first proof point for the implied acceleration (6.6-9.3% yoy growth required for the remainder of the year to reach the 4-6% FY guidance). Our preview in detail:

Q2 group sales are seen to increase 6.2% yoy to € 55m (eNuW), implying H1 sales of € 108m (+1.6% yoy). In segment detail:
  • Functional Fillers sales are estimated at € 40.5m, up 6% yoy (eNuW). The return to growth should be carried by fine hydroxides (FH) as demand for environmentally friendly flame retardants used in data centre cables continues to accelerate (reaffirmed by key cable manufacturers such as Nexans and Prysmian). Viscosity optimized hydrates (VH) look set to continue their strong momentum (Q1: +28% yoy; eNuW Q2: +35% yoy to € 6m). Yet, boehmites should remain a drag with a flat-ish yoy sales development. Mind you, while battery cells (boehmite application area) are largely produced in China, the pack assembly and assembly into the car is indeed done in Europe (VH).
  • Specialty Alumina sales are estimated at € 14.5m, +6.6% yoy (eNuW) as demand from key end markets such as the refractory industry should have passed the trough.

Q2 EBIT is expected at € 4.1m (7.4% margin, eNuW). While the margin is seen to be down 1.7pp yoy (burdened by risen energy prices but also higher levels of depreciation stemming from the ongoing production capacity buildouts), we expect it to show notable improvement compared to the last two quarters. Mind you, the scheduled maintenance of the waste incineration plant next to the German site (key supplier of production-relevant steam) falls into Q2/Q3. So far, the process has been running smoothly, not forcing NTG to produce its own steam using LNG at currently elevated prices, which is reflected in the lower end of the FY margin guidance.

Guidance check. H1 growth would stand at 1.6% yoy with further sequential improvements expected, putting the FY sales growth guidance of 4-6% (eNuW: 4.2%) well in reach. On profitability, an H1 EBIT margin of 6.3% (eNuW) supports our view that the lower end of the 5-7% EBIT margin guidance looks rather conservative, especially in light of an improving top-line momentum in H2, compensating for potential input cost risks.

Attractive long-term set-up. Nabaltec is a globally leading player in the market for environmentally friendly flame retardants, which is driven by tight regulations and structurally growing demand, especially in the area of data centres. New products such as VH add additional growth levers. Despite the currently challenging specialty chemicals market, Nabaltec stands out with a strong balance sheet, still good margins and plenty of capacity (€ 300m revenue potential, eNuW) to be utilized during the mid- to long-term, not adequately reflected by the current valuation.

We confirm our BUY rating with an unchanged € 16 PT based on FCFY26e.
 

You can download the research here: nabaltec-ag-2026-07-30-previewreview-en-55d88
For additional information visit our website: https://www.nuways-ag.com/research

Contact for questions:
NuWays AG - Equity Research
Web: www.nuways-ag.com
Email: research@nuways-ag.com
LinkedIn: https://www.linkedin.com/company/nuwaysag
Adresse: Mittelweg 16-17, 20148 Hamburg, Germany
++++++++++
Diese Meldung ist keine Anlageberatung oder Aufforderung zum Abschluss bestimmter Börsengeschäfte.
Offenlegung möglicher Interessenkonflikte nach § 85 WpHG beim oben analysierten Unternehmen befindet sich in der vollständigen Analyse.
++++++++++


The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
View original content: EQS News


2373992  30.07.2026 CET/CEST

Source : Webdisclosure.com

© 2026 Tous droits réservés
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière